Open Access
Issue
EPJ Web Conf.
Volume 348, 2026
3rd International Conference on Innovations in Molecular Structure & Instrumental Approaches (ICMSI 2026)
Article Number 02001
Number of page(s) 22
Section Chemistry
DOI https://doi.org/10.1051/epjconf/202634802001
Published online 21 January 2026
  1. L. Miao, M. Xiaoyan, J. Weiling, Z. Jun, L. Wukun, W. Shuang, L. Huiguo, Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China, Eur. J. Med. Chem., 232, 114168–114170 (2022) [Google Scholar]
  2. J. Maryam, S. Mohammad, S. Farzad, H. Sajjad, T. Muhammad, A. Otman, A. Sepideh, K. Daria, R. Navid, R. Mohammad, H. Golnaz, H. Mahnaz, N. Ehsan, R. Mohammad, Metal nanoparticles-assisted early diagnosis of diseases, OpenNano, 8, 2352–9520 (2022) [Google Scholar]
  3. C. Chao, L. He, X. Hao, Z. Dancheng, S. Chao, Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases, Dalton Trans., 52, 671–683 (2023) [Google Scholar]
  4. R. Lloyd, X. Zhi-Qiang, S. Ronald, L. Emma, K. Celine, L. Barry, J. David, D. Martin, E. Nicholas, L. Jennifer, F. Stephen, T. Carolyn, An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase, J. Inorg. Biochem., 142, 28–38 (2015) [Google Scholar]
  5. M. Mohamed, A. Sh, A. Haifa, K. Tasneam, M. Mohamed, Gold nanoparticles in microelectronics advancements and biomedical applications, Mater. Sci. Eng. B, 301, 0921–5107 (2024) [Google Scholar]
  6. H. Amran, R. Thohid, M. Md Hosne, H. Israfil, H. Nayem, I. Safiul, A. Abdullah, Advances and significances of gold nanoparticles in cancer treatment: A comprehensive review, Results Chem., 8, 2211–7156 (2024) [Google Scholar]
  7. Y. Chen, Y. Jia, W. Song, L. Zhang, Therapeutic potential of nitrogen mustard based hybrid molecules, Front. Pharmacol., 17, 1453–1464 (2018) [Google Scholar]
  8. T. Marzo, D. Cirri, C. Gabbiani, T. Gamberi, F. Magherini, A. Pratesi, A. Guerri, T. Biver, F. Binacchi, M. Stefanini, A. Arcangeli, L. Messori, Auranofin, Et3PAuCl, and Et3PAuI are highly cytotoxic on colorectal cancer cells: a chemical and biological study, ACS Med. Chem. Lett., 8, 997–1001 (2017) [Google Scholar]
  9. M.K. Dholaria, P.V., & Kapadiya, K.M., Synthesis of Lanso Aminopyrimidines as Dominant Chemotherapeutic Agents for Leukaemia, Russ. J. Org. Chem., 56, 1995–2004 (2020) [Google Scholar]
  10. A. Shah, N. Teraiya, J.H. Kamdar, T. Juneja, C.B. Sangani, S. Ahmed, K. Kapadiya, Novel purine derivatives as selective CDK2 inhibitors with potential anticancer activities: Design, synthesis and biological evaluation, Bioorg. Chem., 153, 107841 (2024) [Google Scholar]
  11. D. Yevale, N. Teraiya, T. Lalwani, M. Dalasaniya, K. Kapadiya, R.K. Ameta, C.B. Sangani, Y. Duan, PI3K5 and mTOR dual inhibitors: Design, synthesis and anticancer evaluation of 3-substituted aminomethylquinoline analogues, Bioorg. Chem., 147, 107323 (2024) [Google Scholar]
  12. K. Kapadiya, K. Kavadia, J. Gohel, R. Khunt, Regioselective synthesis of triazolo[3, 4-e]purine derivatives and their anti-cancer activity against NCI-60 cell-lines, Folia Med. (Plovdiv), 63(2), 213–220 (2021) [Google Scholar]
  13. J J.N. Gohel, K.S. Lunagariya, K.M. Kapadiya, R.C. Khunt, An efficient protocol for the synthesis of 1, 5-disubstituted tetrazole derivatives via a TMS-N3 based Ugi reaction and their anti-cancer activity, ChemistrySelect, 3, 11657 (2018) [Google Scholar]
  14. M. Malet-Martino, R. Martino, Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): A review, Oncologist, 7, 288–323 (2002) [Google Scholar]
  15. C. Sordo-Bahamonde, S. Lorenzo-Herrero, A. Gonzalez-Rodriguez, A. Martinez-Pérez, J. Rodrigo, J. Garcia-Pedrero, S. Gonzalez, Chemo-immunotherapy: A new trend in cancer treatment, Cancers (Basel), 25, 2912–2918 (2023) [Google Scholar]
  16. G.K. Dhuda, K. Kapadiya, P. Ladva, A. Jivani, J. Modha, Click chemistry-based synthesis of new 1-formyl-naphthalen-2-yloxymethyl-1, 2, 3-triazoles, anticancer screening and 2D-NMR studies, Anal. Chem. Lett., 11(6), 756–770 (2021) [Google Scholar]
  17. G. Yosi, G. Gary, M. David, W. Bert, Drug combination in cancer treatment—From cocktails to conjugated combinations, Cancers (Basel), 13, 669–714 (2021) [Google Scholar]
  18. B.L. Gondaliya, K.M. Kapadiya, HAuCL catalyzed and dibenzyl amine centered A3 coupling reaction: Synthesis, spectroscopic proofing and anti-microbial efficacy, ChemistrySelect, 8, e202302047 (2023) [Google Scholar]
  19. S. Kausar, K. Said, M. Ishaq, M. Akram, M. Riaz, G. Rasool, K. Hamid, I. Saleem, S. Shamim, A. Malik, Mechanism of action of antiviral drugs, Int. J. Immunopathol. Pharmacol., 35, 1–12 (2021) [Google Scholar]
  20. B. Aghili, S. Rahbarpour, M. Berahman, A. Horri, Influence of surface roughness on the work function of gold: A density functional theory study, J. Phys. Chem., 19, 8077–8084 (2024) [Google Scholar]
  21. N. Thang, T. Chien, D. Cuong, Polymer-based hydrogels applied in drug delivery: An overview, Gels, 27, 523–542 (2023) [Google Scholar]
  22. H. Javid, M. Sharbaf, S. Yazdani, O. Akbari, S. Akbari, N. Rezagholinejad, M. Tajaldini, M. Karimi-Shahri, The role of viruses in cancer development versus cancer therapy: An oncological perspective, Cancer Med., 12, 11127–11148 (2023) [Google Scholar]
  23. M. Asadi, S. Ghorbani, L. Mahdavian, M. Aghamohammadi, Graphene-based hybrid composites for cancer diagnostic and therapy, J. Transl. Med., 22, 611–623 (2024) [Google Scholar]
  24. S. Kumar, M. Shukla, A. Sharma, G. Jayaprakash, R. Tonk, D. Chellappan, S. Singh, K. Dua, F. Ahmed, S. Bhattacharyya, D. Kumar, Metal-based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy, MedComm, 4, 253–258 (2023) [Google Scholar]
  25. S. Carabineiro, Supported gold nanoparticles as catalysts for the oxidation of alcohols and alkanes, Front. Chem., 7, 702–726 (2019) [Google Scholar]
  26. C. Ruiqi, M. Yulin, L. Huanxin, F. Chaopeng, Electronic structure regulation in the design of low-cost efficient electrocatalysts: From theory to applications, Nano Energy, 115, 2211–2855 (2023) [Google Scholar]
  27. M. Chiang, Y. Yang, C. Nicol, C. Wang, Gold nanoparticles in neurological diseases: A review of neuroprotection, Int. J. Mol. Sci., 25, 2360–2374 (2024) [Google Scholar]
  28. A. Shah, N. Teraiya, C. Sangani, M. Muddassir, K. Kapadiya, N. Patel, AlCL catalyzed Groebke-Blackburn-Bienaymé reaction for the synthesis of imidazo[1, 2-b]isoquinolin-3-amine derivatives: Design, synthesis, and selective COX-II inhibitors, ChemistrySelect, 10(41), e03350 (2025) [Google Scholar]
  29. J. Kuchhadiya, K. Kapadiya, Last decades' overview on tandem catalysis: Intrigue in organo-metallic chemistry, Mini-Rev. Org. Chem., 22(1), e300124226546 (2025) [Google Scholar]
  30. R.I. Piludiya, P.V. Dholaria, A.J. Jivani, et al., Bis-triazole heterocycles as antitubercular and antimicrobial agents: Synthesis using copper-catalyzed click chemistry approach, Russ. J. Org. Chem., 58, 1280–1286 (2022) [Google Scholar]
  31. S.C. Butani, M.K. Vekariya, P.V. Dholaria, et al., Copper(I)-catalyzed click chemistry-based synthesis and antimicrobial evaluation of triazolopyridine-triazole congeners, Russ. J. Org. Chem., 58, 405–411 (2022) [Google Scholar]
  32. K. Kapadiya, Y. Jadeja, R. Khunt, Synthesis of purine-based triazoles by copper(I)-catalyzed Huisgen azide-alkyne cycloaddition reaction, J. Heterocycl. Chem., 55(1), 199–208 (2017) [Google Scholar]
  33. J. Vines, J. Yoon, N. Ryu, D. Lim, H. Park, Gold nanoparticles for photothermal cancer therapy, Front. Chem., 7, 167–172 (2019) [Google Scholar]
  34. A. Angela, B. Benjamin, W. Margot, The promise of self-assembled 3D supramolecular coordination complexes for biomedical applications, Inorg. Chem., 56, 14715–14729 (2017) [Google Scholar]
  35. J. Gorgeous, N. AlSawaftah, W.H. Abuwatfa, G.A. Husseini, Review of gold nanoparticles: Synthesis, properties, shapes, cellular uptake, targeting, release mechanisms and applications in drug delivery and therapy, Pharmaceutics, 16, 1332 (2024) [Google Scholar]
  36. F.H. Abdalbari, C.M. Telleria, The gold complex auranofin: New perspectives for cancer therapy, Discov. Oncol., 12, 42 (2021) [Google Scholar]
  37. P.A. Yakkala, N.R. Penumallu, S. Shafi, A. Kamal, Prospects of topoisomerase inhibitors as promising anti-cancer agents, Pharmaceutics, 16, 1456 (2023) [Google Scholar]
  38. S. Jain, D.G. Hirst, J.M. O'Sullivan, Gold nanoparticles as novel agents for cancer therapy, Br. J. Radiol., 85, 101–113 (2012) [Google Scholar]
  39. S.C. Gupta, C. Sundaram, S. Reuter, B.B. Aggarwal, Inhibiting NF-kB activation by small molecules as a therapeutic strategy, Biochim. Biophys. Acta, 1799, 775–787 (2010) [Google Scholar]
  40. D. Placha, J. Jampilek, Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems, Pharmaceutics, 13, 64 (2021) [Google Scholar]
  41. G. McDonnell, A.D. Russell, Antiseptics and disinfectants: Activity, action, and resistance, Clin. Microbiol. Rev., 12, 147–179 (1999) [CrossRef] [PubMed] [Google Scholar]
  42. M. Kitching, M. Ramani, E. Marsili, Fungal biosynthesis of gold nanoparticles: Mechanism and scale-up, Microb. Biotechnol., 8, 904–917 (2015) [Google Scholar]
  43. G. Annunziato, Strategies to overcome antimicrobial resistance (AMR) making use of non-essential target inhibitors: A review, Int. J. Mol. Sci., 20, 5844 (2019) [Google Scholar]
  44. S. Manoharan, G.J. Guillemin, R.S. Abiramasundari, M.M. Essa, M. Akbar, M.D. Akbar, The role of reactive oxygen species in the pathogenesis of Alzheimer's disease, Parkinson's disease, and Huntington's disease: A mini review, Oxid. Med. Cell Longev., 16, 8590578 (2016) [Google Scholar]
  45. M.C. Chiang, Y.P. Yang, C.J.B. Nicol, C.J. Wang, Gold nanoparticles in neurological diseases: A review of neuroprotection, Int. J. Mol. Sci., 25, 2360 (2024) [Google Scholar]
  46. H. Huang, R. Liu, J. Yang, J. Dai, S. Fan, J. Pi, Y. Wei, X. Guo, Gold nanoparticles: Construction for drug delivery and application in cancer immunotherapy, Pharmaceutics, 15, 1868 (2023) [Google Scholar]
  47. Y. Zhuo, Y.G. Zhao, Y. Zhang, Enhancing drug solubility, bioavailability, and targeted therapeutic applications through magnetic nanoparticles, Molecules, 29, 4854 (2024) [Google Scholar]
  48. S. Ahn, S.Y. Jung, S.J. Lee, Gold nanoparticle contrast agents in advanced X-ray imaging technologies, Molecules, 18, 5858–5890 (2013) [Google Scholar]
  49. J. Tai, S. Fan, S. Ding, L. Ren, Gold nanoparticles-based optical biosensors for cancer biomarker proteins: A review of the current practices, Front. Bioeng. Biotechnol., 10, 877193 (2022) [Google Scholar]
  50. P.P.P. Kumar, R. Mahajan, Gold polymer nanomaterials: A promising approach for enhanced biomolecular imaging, Nanotheranostics, 8, 64–89 (2024) [Google Scholar]
  51. S. Craig, L. Gao, I. Lee, T. Gray, A.J. Berdis, Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation, J. Med. Chem., 55, 2437–2451 (2012) [Google Scholar]
  52. I. Tolbatov, A. Marrone, C. Coletti, R. Re, Computational studies of Au(I) and Au(III) anticancer metallodrugs: A survey, Molecules, 26, 7600 (2021) [Google Scholar]
  53. V. Milacic, Q.P. Dou, The tumor proteasome as a novel target for gold(III) complexes: Implications for breast cancer therapy, Coord. Chem. Rev., 253, 1649–1660 (2009) [Google Scholar]
  54. M.K.Y. Soliman, S.S. Salem, M. Abu-Elghait, M.S. Azab, Biosynthesis of silver and gold nanoparticles and their efficacy towards antibacterial, antibiofilm, cytotoxicity, and antioxidant activities, Appl. Biochem. Biotechnol., 195, 1158–1183 (2023)2 [Google Scholar]
  55. J. Schubert, M. Chanana, Coating matters: Review on colloidal stability of nanoparticles with biocompatible coatings in biological media, living cells, and organisms, Curr. Med. Chem., 25, 4553–4586 (2018) [Google Scholar]
  56. T.T. Paterlini, L.F.B. Nogueira, C.B. Tovani, M.A.E. Cruz, R. Derradi, A.P. Ramos, The role played by modified bioinspired surfaces in interfacial properties of biomaterials, Biophys. Rev., 9, 683–698 (2017) [Google Scholar]
  57. A. Rusu, I.M. Moga, L. Uncu, G. Hancu, The role of five-membered heterocycles in the molecular structure of antibacterial drugs used in therapy, Pharmaceutics, 15, 2554 (2023) [Google Scholar]
  58. S. Jain, D.G. Hirst, J.M. O'Sullivan, Gold nanoparticles as novel agents for cancer therapy, Br. J. Radiol., 85, 101–113 (2012) [Google Scholar]
  59. R. Smith, H. Müller-Bunz, X. Zhu, Investigation of a-Thioglycoside Donors: Reactivity Studies toward Configuration-Controlled Orthogonal Activation in One-Pot Systems, Org. Lett., 18, 3578 (2016) [Google Scholar]
  60. X. Zhu, K. Pachamuthu, R.R. Schmidt, J. Org. Chem., Convergent Synthesis of Peptide Conjugates Using Dehydroalanines for Chemoselective Ligations, 68, 5641 (2003); (b) X. Zhu, R.R. Schmidt, Eur. J. Org. Chem., Synthesis of a-glycosyl thiols by stereospecific ring-opening of 1, 6-anhydrosugars, 41, 4069 (2003) [Google Scholar]
  61. P.S. Pregosin, E.D. Becker, 'H-NMR spectroscopy of gold drugs. High-resolution studies of β-D-thioglucosetetraacetate phosphine complexes of Au(I), Helv. Chim. Acta, 66, 1436–1440 (1983) [Google Scholar]
  62. P. Shu, J. Zeng, J. Tao, Y. Zhao, G. Yao, Q. Wan, Selective S-deacetylation inspired by native chemical ligation: Practical syntheses of glycosyl thiols and drug mercapto-analogues, Green Chem., 17, 2545–2551 (2015) [Google Scholar]
  63. M.T. Razi, P.J. Sadler, D.T. Hill, B.M. Sutton, Proton, carbon-13, and phosphorus-31 nuclear magnetic resonance studies of (2, 3, 4, 6-tetra-O-acetyl-1 -thio-β-D-glucopyranosato-S)-(triethylphosphine) gold (auranofin), a novel antiarthritic agent, J. Chem. Soc. Dalton Trans., 7, 1331–1334 (1983) [Google Scholar]
  64. J. Wang, X. Mi, J. Wang, Y. Yang, An efficient approach to chloro(organophosphine) gold(I) complexes for the synthesis of auranofin, Green Chem., 19, 634–637 (2017) [Google Scholar]
  65. O. Dada, G. Sánchez-Sanz, M. Tacke, X. Zhu, Synthesis and anticancer activity of novel NHC-gold(I)-sugar complexes, Tetrahedron Lett., 59, 2904–2908 (2018) [Google Scholar]
  66. W. Henderson, B.K. Nicholson, S.J. Faville, D. Fan, J.D. Ranford, Gold(III) thiosalicylate complexes containing cycloaurated 2-arylpyridine, 2-anilinopyridine, and 2-benzylpyridine ligands, J. Organomet. Chem., 631, 41–46 (2001) [Google Scholar]
  67. P. Tshuma, B.C.E. Makhubela, N. Bingwa, A. Mehlana, Palladium (II) Immobilized on Metal-Organic Frameworks for Catalytic Conversion of Carbon Dioxide to Formate, Inorg. Chem., 59, 6717–6728 (2020) [Google Scholar]
  68. Fuchita, H. Ieda, S. Wada, S. Kameda, M. Mikuriya, Organogold(III) complexes derived from auration reactions of thienyl-substituted pyridine derivatives, J. Chem. Soc. Dalton Trans., 24, 4431–4435 (1999) [Google Scholar]
  69. E. Abás, D. Aguirre-Ramirez, M. Laguna, L. Grasa, Gold(III) complexes activity against multidrug-resistant bacteria of veterinary significance, Biomedicines, 9, 1775 (2021) [Google Scholar]
  70. V. Fernández-Moreira, R.P. Herrera, M.C. Gimeno, Anticancer properties of gold complexes with biologically relevant ligands, Pure Appl. Chem., 18, 5262 (2018) [Google Scholar]
  71. J.H. Docherty, T.M. Lister, G. Mcarthur, M.T. Findlay, P. Domingo-Legarda, J. Kenyon, S. Choudhary, I. Larrosa, Transition-metal-catalyzed C-H bond activation for the formation of C-C bonds in complex molecules, Chem. Rev., 123, 7692–7760 (2023) [Google Scholar]
  72. H.B. Rahuman, R. Dhandapani, S. Narayanan, V. Palanivel, R. Paramasivam, R. Subbarayalu, S. Thangavelu, S. Muthupandian, Medicinal plants mediated the green synthesis of silver nanoparticles and their biomedical applications, IET Nanobiotechnol., 16, 115–144 (2022) [Google Scholar]
  73. Y. Ma, S. Bian, Y. Shi, X. Fan, X. Kong, Size effect on aurophilic interaction in gold-chloride cluster anions of Au□Cl□+1 (2 ≤ n ≤ 7), ACS Omega, 4, 650–654 (2019) [Google Scholar]
  74. P.P.P. Kumar, D.K. Lim, Gold-polymer nanocomposites for future therapeutic and tissue engineering applications, Pharmaceutics, 14, 70 (2021) [Google Scholar]
  75. G. Genchi, A. Carocci, G. Lauria, M.S. Sinicropi, A. Catalano, Nickel: Human health and environmental toxicology, Int. J. Environ. Res. Public Health, 17, 679 (2020) [Google Scholar]
  76. M. Kus-Liskiewicz, P. Fickers, I. Ben Tahar, Biocompatibility and cytotoxicity of gold nanoparticles: Recent advances in methodologies and regulations, Int. J. Mol. Sci., 22, 10952 (2021) [Google Scholar]
  77. C.D. Hein, X.M. Liu, D. Wang, Click chemistry, a powerful tool for pharmaceutical sciences, Pharm. Res., 25, 2216–2230 (2008) [Google Scholar]
  78. J. Xiong, J. Chen, P.S. Lee, Functional fibers and fabrics for soft robotics, wearables, and human-robot interface, Adv. Mater., 33, e2002640 (2021) [Google Scholar]
  79. D.M. Alshangiti, T.K. El-Damhougy, A. Zaher, M. Madani, M. Mohamady Ghobashy, Revolutionizing biomedicine: Advancements, applications, and prospects of nanocomposite macromolecular carbohydrate-based hydrogel biomaterials: A review, RSC Adv., 13, 35251–35291 (2023) [Google Scholar]
  80. N. Uehara, Polymer-functionalized gold nanoparticles as versatile sensing materials, Anal. Sci., 26, 1219–1228 (2010) [Google Scholar]
  81. J.P.M. Almeida, A.L. Chen, A. Foster, R. Drezek, In vivo biodistribution of nanoparticles, Nanomedicine, 6, 815–835 (2011) [Google Scholar]
  82. M. Haripriyaa, K. Suthindhiran, Pharmacokinetics of nanoparticles: Current knowledge, future directions and its implications in drug delivery, Futur. J. Pharm. Sci., 9, 113 (2023) [Google Scholar]
  83. M.F. Hornos Carneiro, F. Barbosa Jr., Gold nanoparticles: A critical review of therapeutic applications and toxicological aspects, J. Toxicol. Environ. Health B Crit. Rev., 19, 129–148 (2016) [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.